[ad_1]
If we get sick, there is a cure. We have wanted to hear that for some time. Now the working group of doctors says that in the “dark night” of the pandemic, between the end of February and the month of March, when there were 30 new pneumonia a day and the intensive care units of hospitals were filling, it began to work with he Baricitinib, a medicine used to treat rheumatoid arthritis.
Doctors worked silently, observed patient response, collected data, and developed statistics from it to arrive at a death rate of 0.006 percent among patients who underwent such treatment. Now the University of Verona, with the integrated university hospital and the Peschiera Pederzoli hospital, announces it with pride. Because the results of the study were published yesterday in the Journal of clinical research from New York and show that the negative consequences of the pandemic may be limited. The study is of great relevance to healthcare systems around the world.
Extensive report on L’Arena on newsstands
Maria Vittoria Adami
